The American Journal of Managed Care

Christian John Lillis Shares Goals of the Peggy Lillis Foundation's "See C. Diff" Campaign

Amid National C. Diff Awareness Month, Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C. Diff Education & Advocacy, explains the foundation's "See C. diff" ...
The American Journal of Managed Care

Christian John Lillis Lists Benefits of Microbiome-Based Therapeutics for C difficile Treatment

Christian John Lillis, cofounder and executive director of the Peggy Lillis Foundation for C difficile Education & Advocacy, explained how FDA-approved microbiome-based therapeutics help to treat and ...
Digital Journal

Awarding those taking a stand against C diff infection

A nurse prepares the Pfizer Covid-19 vaccine at a public housing project pop-up site targeting vulnerable communities in Los Angeles. — Photo: © AFP A nurse ...
EurekAlert!

C. diff uses toxic compound to fuel growth advantage

Matthew Munneke, left, and Eric Skaar, PhD, MPH, use anaerobic chambers to study bacteria like C. diff that die in the presence of oxygen. The pathogen C. diff — the most common cause of health ...
Healthline

What to Know About C. Diff (Clostridioides Difficile) Infection Recurrence

Recurrent C. diff infection is when you contract a C. diff infection 2 to 8 weeks after completing treatment for a previous one. C. diff relapse is a recurrence of the same strain, while reinfection ...